IGET disposable vapes, combustible cigarettes and approved smoking-cessation medicines are different product categories. A useful comparison should explain those differences without describing a consumer vape as a proven medical substitute.
Cigarettes rely on combustion
Cigarettes burn tobacco and produce smoke. Vapes use battery-powered heating to produce an aerosol. That difference changes the exposure profile, but it does not establish that a particular IGET product is harmless or medically appropriate.
Consumer disposable vapes are hardware products
An IGET model can be compared by battery, coil, charging support, dimensions and product format. Those specifications do not demonstrate smoking-cessation efficacy. Product popularity and customer reviews are also not clinical evidence.
Nicotine-replacement and prescription medicines are evaluated differently
Established quit-smoking medicines and nicotine-replacement therapies have defined therapeutic uses and evidence bases. A health professional can help select an option based on smoking history, dependence, previous quit attempts and other health factors.
Therapeutic vapes in Australia are a separate regulatory pathway
The TGA explains that therapeutic vapes can be considered in specific circumstances but remain unapproved therapeutic goods. They are not first-line treatment and have not been included in the ARTG after the normal pre-market evaluation process.
Current access rules matter
The TGA supply guidance states that vapes are only lawfully available for therapeutic purposes through pharmacy settings. An ordinary online consumer listing should not be treated as evidence that a product is a lawful therapeutic vape.
Bottom line
IGET, cigarettes and quit medicines should not be collapsed into a simple “better alternative” ranking. Hardware comparisons are appropriate for product information; treatment decisions belong in an evidence-based health context.